Remogliflozin etabonate-d7, CAS [[1233515-93-9]] Preis auf Anfrage

Product Overview

• Article Name: Remogliflozin etabonate-d7, CAS [[1233515-93-9]] Preis auf Anfrage
• Biozol Catalog Number: MCE-HY-166548S
• Supplier Catalog Number: HY-166548S
• Alternative Catalog Number: MCE-HY-166548S-1UNIT
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: GSK189075-d7

Product Description

Remogliflozin etabonate-d7 (GSK189075-d7) is the deuterium labeled Remogliflozin etabonate. Remogliflozin etabonate (GSK189075) is an orally active, selective and low-affinity sodium glucose cotransporter (SGLT2) inhibitor with Ki values of 1.95 µM, 2.14 µM, 43.1 µM, 8.57 µM for hSGLT2, rSGLT2, hSGLT1, rSGLT1, respectively. Remogliflozin etabonate is a proagent based on benzylpyrazole glucoside and is metabolized to its active form, Remogliflozin, in the body. Remogliflozin etabonate exhibits antidiabetic efficacy in rodent models[1].

Product Properties

• Molecular Weight: 529.63
• CAS Number: [1233515-93-9]
• Formula: C26H31D7N2O9
• Target: Isotope-Labeled Compounds,SGLT

Application Notes

• Application Notes: MCE Product type: Isotope-Labeled Compounds